Esther Papaseit
Clinical pharmacologist and researcher in the Human Pharmacology and Clinical Neurosciences research group at Hospital del Mar Medical Research Institute (IMIM), Barcelona
Data updated
Research Footprint
Esther Papaseit appears in 5 tracked papers (2016–2023), most studied alongside MDMA, 2C-X and Mescaline, across Medicinal Chemistry & Drug Development, Interpersonal Functioning & Social Connectedness and Healthy Volunteers.
Most-cited paper: Human pharmacology of mephedrone in comparison with MDMA (149 citations).
Frequent co-authors: Magí Farré, Marta Torrens and Rafael Torre.
Background & Research
Esther Papaseit Fontanet is a Spanish clinical pharmacologist associated with the Human Pharmacology and Clinical Neurosciences research group at Hospital del Mar Medical Research Institute (IMIM) in Barcelona, with ties to Universitat Autònoma de Barcelona. Her work focuses on human pharmacology of new psychoactive substances and classical entactogens, including controlled administration studies and observational research on MDMA, mephedrone, methylone, and 2C-B.
Key Impact
She is a key human laboratory pharmacology researcher whose controlled studies of MDMA, mephedrone, methylone, and 2C-B help define the acute effects, pharmacokinetics, and safety of psychedelic/entactogenic drugs.
Collaboration Network
7 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Esther Papaseit is associated with.
Hospital del Mar Medical Research Institute (IMIM), Barcelona
A Barcelona-based biomedical research institute linked to Hospital del Mar and integrated with clinical research and health innovation programs.
View stakeholder →Universitat Autònoma de Barcelona
Universitat Autonoma de Barcelona is a major public research university in Spain with psychiatry and neuroscience programs that have contributed to psychedelic and psychopharmacology research.
View stakeholder →